001564293 000__ 03840nam\\2200709\i\4500 001564293 001__ 1564293 001564293 003__ Credo 001564293 005__ 20241203003324.0 001564293 006__ m\\\\\o\\d\\\\\\\\ 001564293 007__ cr\cn\nnnunnun 001564293 008__ 210415r20212021nyua\\\\ob\\\\000\0\eng\d 001564293 010__ $$z 2019052521 001564293 020__ $$a9781787858602$$q(electronic book) 001564293 020__ $$z9780826142993 001564293 020__ $$z0826142990 001564293 020__ $$z9780826143129$$q(electronic book) 001564293 020__ $$z0826143121$$q(electronic book) 001564293 035__ $$a(CaBNVSL)gtp00568737 001564293 035__ $$a(Credo)spffamcao2021 001564293 035__ $$a(OCoLC)1247156943 001564293 040__ $$aCaBNVSL$$beng$$erda$$cCaBNVSL$$dCaBNVSL 001564293 050_4 $$aRM666.C266$$bS65 2021eb 001564293 060_4 $$aWL 704.6$$bS457f 2021eb 001564293 08204 $$a615.3/23648$$223 001564293 1001_ $$aSmith, Gregory L.,$$eauthor. 001564293 24510 $$aFast facts about medical cannabis and opioids :$$bminimizing opioid use through cannabis /$$cGregory L. Smith, Kevin F. Smith. 001564293 250__ $$a[Enhanced Credo edition] 001564293 263__ $$a20210505 001564293 264_1 $$aNew York, NY :$$bSpringer Publishing Company, LLC,$$c[2021] 001564293 26431 $$aBoston, Massachusetts :$$bCredo Reference,$$c2021. 001564293 300__ $$a1 online resource (32 entries) :$$b33 images 001564293 336__ $$atext$$2rdacontent 001564293 336__ $$astill image$$2rdacontent 001564293 337__ $$aelectronic$$2isbdmedia 001564293 338__ $$aonline resource$$2rdacarrier 001564293 4901_ $$aFast facts 001564293 504__ $$aIncludes bibliographical references. 001564293 5050_ $$aPreface -- Acknowledgments -- Part I. The opioid epidemic: 1. Chronic pain and opioids; 2. Current costs of the opioid epidemic; 3. Opioid use disorder -- Part II. Overview of cannabis: 4. History and legality of cannabis; 5. Overview of the endocannabinoid system -- Part III. Cannabinoids: 6. Cannabinoids and terpenes; 7. Synthetic cannabinoid pharmaceuticals; 8. Isolate cannabinoid pharmaceuticals -- Part IV. Medical marijuana: 9. Medical marijuana and bioavailability; 10. Side effects of cannabis use -- Part V. Chronic pain management: 11. Causes of chronic pain; 12. Treating chronic pain with opioids; 13. Treating chronic pain with cannabinoids -- Part VI. Cannabinoids and the opioid crisis: 14. Cannabinoid and opioid interactions; 15. Cannabis as an adjunct to opioids; 16. Opioid sparing with cannabinoids -- Appendix A. Centers for Disease Control and Prevention guideline for prescribing opioids for chronic pain -- Appendix B. National Institutes of Drug Abuse quick screen and NIDA-Modified ASSIST screenings for opioid use disorder -- Appendix C. Centers for Disease Control and Prevention calculating total daily dose of opioids for safer dosage. 001564293 506__ $$aAccess limited to authorized users. 001564293 588__ $$aDescription based on print version record. 001564293 65012 $$aChronic Pain$$xdrug therapy. 001564293 65012 $$aPain Management. 001564293 65022 $$aCannabinoids$$xtherapeutic use. 001564293 65022 $$aMedical Marijuana$$xtherapeutic use. 001564293 65022 $$aAnalgesics, Opioid$$xadverse effects. 001564293 65022 $$aOpioid-Related Disorders$$xprevention & control. 001564293 650_0 $$aChronic pain$$xTreatment.$$xPsychological aspects$$0(DLC)sh2009119627 001564293 650_0 $$aCannabinoids$$xTherapeutic use. 001564293 650_0 $$aOpioids$$xTherapeutic use. 001564293 655_2 $$aNurses Instruction. 001564293 655_0 $$aElectronic books 001564293 7001_ $$aSmith, Kevin$$q(Kevin F.),$$eauthor.$$0(OCoLC)oca01692929 001564293 7102_ $$aCredo Reference (Firm),$$edistributor. 001564293 77608 $$iPrint version:$$z0826142990$$z9780826142993$$w(DLC) 2019052521 001564293 830_0 $$aFast facts (Springer Publishing Company) 001564293 852__ $$bebk 001564293 85640 $$3Credo Reference $$uhttps://univsouthin.idm.oclc.org/login?url=https://search.credoreference.com/books/Qm9va1R5cGU6MjYy?aid=98124$$zOnline Access 001564293 909CO $$ooai:library.usi.edu:1564293$$pGLOBAL_SET 001564293 980__ $$aBIB 001564293 980__ $$aEBOOK 001564293 982__ $$aEbook 001564293 983__ $$aOnline